Stem Cell Biomarkers and Drug Targets
Imaging biomarkers permit prior recognition of ailment contrasted with sub-atomic biomarkers, and smooth out translational examination in the medication revelation commercial center. Since they are mishmash, no body drug exists to assault them.
New biomarker in disease stem cells that oversee malignant growth endurance and spread, and it's raising expectation that drug revelation to destroy malignancy stem cells.
With the revelation that our human undifferentiated cell model had anticipated precisely what was occurring in patients.